The Ventana INFORM HER2 Dual In Situ Hybridization (DISH) DNA Probe Cocktail Assay Versus Fluorescence In Situ Hybridization (FISH): Focussed Study of Immunohistochemical 2+Cases

被引:0
|
作者
Gao, F. F. [1 ]
Dabbs, D. J. [1 ]
Bhargava, R. [1 ]
机构
[1] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Pittsburgh, PA 15213 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
2051
引用
收藏
页码:493A / 493A
页数:1
相关论文
共 50 条
  • [41] Comparison of dual-color dual-hapten brightfield in situ hybridization (DDISH) and fluorescence in situ hybridization in breast cancer HER2 assessment
    Kosa, Csaba
    Kardos, Laszlo
    Kovacs, Judit
    Szollosi, Zoltan
    PATHOLOGY RESEARCH AND PRACTICE, 2013, 209 (03) : 147 - 150
  • [42] Comparison of HER2 status determination methods in HER2 (2+) patients: Manual fluorescent in situ hybridization (FISH) vs. dual silver enhanced in situ hybridization (SISH)
    Pehlivanoglu, Burcin
    Serin, Gurdeniz
    Yeniay, Levent
    Zekioglu, Osman
    Gokmen, Erhan
    Ozdemir, Necmettin
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 31 : 36 - 40
  • [43] Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)
    Nitta, Hiroaki
    Hauss-Wegrzyniak, Beatrice
    Lehrkamp, Megan
    Murillo, Adrian E.
    Gaire, Fabien
    Farrell, Michael
    Walk, Eric
    Penault-Llorca, Frederique
    Kurosumi, Masafumi
    Dietel, Manfred
    Wang, Lin
    Loftus, Margaret
    Pettay, James
    Tubbs, Raymond R.
    Grogan, Thomas M.
    DIAGNOSTIC PATHOLOGY, 2008, 3 (1)
  • [44] Correlation of Her2/Neu testing using chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) in breast cancer
    Hanna, WM
    Kwok, K
    LABORATORY INVESTIGATION, 2005, 85 : 35A - 35A
  • [45] Correlation of Her2/neu testing using chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) in breast cancer
    Hanna, WM
    Kwok, K
    MODERN PATHOLOGY, 2005, 18 : 35A - 35A
  • [46] Comparison of HER2 Dual-Color and Fluorescence In Situ Hybridization in Breast Cancer A Cohort Study Emphasizing Equivocal Cases
    Shao, Tiffany
    Wood, Martha
    Wing, Anthony
    Hnatovska, Marta
    Mendes, Maria
    Mullen, J. Brendan
    Chang, Martin C.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (03) : 339 - 345
  • [47] Concordance between immunohistochemistry and fluorescence in situ hybridization for assessment of the HER2
    Cho, S. H.
    Lee, M. R.
    Kim, D. C.
    Lee, K. C.
    Lee, J. H.
    Kwon, H. C.
    Lee, H. S.
    Lee, S.
    BREAST, 2011, 20 : S21 - S21
  • [48] A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells
    Kao, Kai-Jie
    Tai, Chien-Hsuan
    Chang, Wen-Hsin
    Yeh, Ta-Sen
    Chen, Tse-Ching
    Lee, Gwo-Bin
    BIOSENSORS & BIOELECTRONICS, 2015, 69 : 272 - 279
  • [49] Bright-field HER2 dual in situ hybridization (DISH) assay on breast cancer cell blocks: a comparative study with histological sections
    Nishimura, Rieko
    Okamoto, Nami
    Satou, Masakazu
    Kojima, Kenta
    Tanaka, Shinichi
    Yamashita, Natsumi
    BREAST CANCER, 2016, 23 (06) : 917 - 921
  • [50] Bright-field HER2 dual in situ hybridization (DISH) assay on breast cancer cell blocks: a comparative study with histological sections
    Rieko Nishimura
    Nami Okamoto
    Masakazu Satou
    Kenta Kojima
    Shinichi Tanaka
    Natsumi Yamashita
    Breast Cancer, 2016, 23 : 917 - 921